Qualitek Labs Board Meeting on Nov 13 to Approve Unaudited Financial Results

Qualitek Labs Limited has announced a Board of Directors meeting scheduled for November 13, 2026. The primary agenda items include the consideration and approval of the Unaudited Financial Results (Standalone and Consolidated) for the half-year ended September 30, 2026, along with the Limited Review Report. Additionally, the board will discuss and approve a proposal to alter the Memorandum of Association, subject to shareholder approval, and consider convening an Extraordinary General Meeting. The trading window for company securities will remain closed until 48 hours after the declaration of these financial results.